LONDON BROKER RATINGS: Citi cuts United Utilities and Severn Trent
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 1,857.00p on 05-05-2026 at 18:50:07 |
|---|---|
| Change | -44.00p -2.31% |
| Buy | 1,852.00p |
| Sell | 1,851.00p |
| Last Trade: | Unknown 17,189.00 at 1,857.00p |
| Day's Volume: | 7,777,805 |
| Last Close: | 1,857.00p |
| Open: | 1,891.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,845.50p - 1,896.00p |
| 52wk Range: | 1,315.00p - 2,282.00p |
| Market Capitalisation: | £74.56b |
| VWAP: | 1,866.28375p |
| Shares in Issue: | 4.02b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 17,189 | 1,857.00p | OTC Trade |
16:52:14 - 05-May-26 |
| Unknown* | 11,061 | 1,857.00p | OTC Trade |
16:52:14 - 05-May-26 |
| Buy* | 7,740 | 1,857.00p | Automatic Execution |
16:35:19 - 05-May-26 |
| Buy* | 7,740 | 1,857.00p | Automatic Execution |
16:35:18 - 05-May-26 |
| Buy* | 10,320 | 1,857.00p | Automatic Execution |
16:35:18 - 05-May-26 |
| Buy* | 3,385 | 1,857.00p | SI Trade |
16:35:17 - 05-May-26 |
| Buy* | 4,713 | 1,857.00p | SI Trade |
16:35:17 - 05-May-26 |
| Buy* | 1,185 | 1,857.00p | SI Trade |
16:35:17 - 05-May-26 |
| Buy* | 275 | 1,857.00p | SI Trade |
16:35:17 - 05-May-26 |
| Buy* | 4,326 | 1,857.00p | SI Trade |
16:35:17 - 05-May-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th May 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 1st May 2026 3:00 pm | RNS | Holding(s) in Company |
| 1st May 2026 3:00 pm | RNS | Total Voting Rights |
| 29th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 29th Apr 2026 7:00 am | RNS | 1st Quarter Results |
| 28th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 28th Apr 2026 7:00 am | RNS | Bepirovirsen priority review US filing acceptance |
| 27th Apr 2026 12:00 pm | RNS | Efimosfermin granted US/EU regulatory designations |
| 27th Apr 2026 7:00 am | RNS | TESARO update on AnaptysBio Inc. litigation |
| 24th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |